ALK-Abelló A/S (OTCMKTS:AKBLF – Get Free Report)’s stock price rose 9.4% during mid-day trading on Monday . The stock traded as high as $38.89 and last traded at $38.89. Approximately 1 shares traded hands during trading, a decline of 100% from the average daily volume of 417 shares. The stock had previously closed at $35.5540.
ALK-Abelló A/S Price Performance
The stock has a 50 day moving average of $33.57 and a 200 day moving average of $34.72.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Featured Stories
- Five stocks we like better than ALK-Abelló A/S
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
